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Hepatitis delta virus (HDV) is a human hepatitis-causing RNA virus,
unrelated to any other taxonomic group of RNA viruses. Its occur-
rence as a satellite virus of hepatitis B virus (HBV) is a singular case
in animal virology for which no consensus evolutionary explanation
exists. Here we present a mammalian deltavirus that does not occur
in humans, identified in the neotropical rodent species Proechimys
semispinosus. The rodent deltavirus is highly distinct, showing a
common ancestor with a recently described deltavirus in snakes.
Reverse genetics based on a tandem minus-strand complementary
DNA genome copy under the control of a cytomegalovirus (CMV)
promoter confirms autonomous genome replication in transfected
cells, with initiation of replication from the upstream genome copy.
In contrast to HDV, a large delta antigen is not expressed and the
farnesylation motif critical for HBV interaction is absent from a ge-
nome region that might correspond to a hypothetical rodent large
delta antigen. Correspondingly, there is no evidence for coinfection
with an HBV-related hepadnavirus based on virus detection and
serology in any deltavirus-positive animal. No other coinfecting
viruses were detected by RNA sequencing studies of 120 wild-
caught animals that could serve as a potential helper virus. The
presence of virus in blood and pronounced detection in reproduc-
tively active males suggest horizontal transmission linked to com-
petitive behavior. Our study establishes a nonhuman, mammalian
deltavirus that occurs as a horizontally transmitted infection, is po-
tentially cleared by immune response, is not focused in the liver, and
possibly does not require helper virus coinfection.
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The genus Deltavirus is an unclassified RNA virus taxon thatcurrently includes only one species, the hepatitis delta virus
(HDV). This virus is an important human pathogen and the only
satellite virus known in animals. For transmission, HDV must
acquire an envelope from a coinfecting hepatitis B virus (HBV;
family Hepadnaviridae, genus Orthohepadnavirus). Following su-
perinfection of HBV-infected individuals, HDV increases the
severity of liver disease (1). Initially detected in 1977 (2), HDV is
present in about 10% of chronically HBV-infected patients (3).
The circular single-stranded RNA genome is ∼1,700 nt long and
is packaged together with the small and large hepatitis delta
antigens (S-HDAg and L-HDAg) into an HDV ribonucleopro-
tein particle that buds with the help of HBV envelope proteins
from HDV/HBV-coinfected hepatocytes. During replication, a
double rolling-circle scheme produces multimeric antigenomic
RNAs that are self-cleaved into monomers by a viroid-like
ribozyme structure. The ligated circular RNA (circRNA) is further
transcribed into multimeric genomic RNAs which also undergo self-
cleavage and ligation (4). Remarkably, HDV RNA replication is
performed by cellular RNA polymerase II (Pol-II), with S-HDAg
being essential in this process, as it coactivates Pol-II by possibly
acting as a histone mimic (5). The RNA genome of HDV folds into
an unbranched rod-like structure due to its high degree of self-
complementarity (6). Budding and interaction with HBV enve-
lope proteins require expression of L-HDAg, which is identical to
S-HDAg except for a 19-amino acid extension at its C terminus,
directed by cellular adenosine deaminase activity that edits the
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amber codon on the antigenomic RNA (7). Posttranslational far-
nesylation of the C terminus of L-HDAg is essential for successful
interaction of the HDV ribonucleoprotein particle with HBV en-
velope proteins (8). HDV has one serotype and is divided into eight
distinct genotypes which show only a moderately structured geo-
graphic distribution (9, 10). The distribution of HBV and HDV
genotypes is also only slightly correlated (11). HDV can be exper-
imentally transmitted to woodchucks that carry replicating wood-
chuck hepatitis virus, but has not been observed in feral animals (12,
13). HDV remains the only human RNA virus for which there is no
known replicating counterpart in other animals.
Recently, deltavirus-like sequences have been found in tran-
scriptome data derived from pooled oropharyngeal and cloacal
samples of teals and ducks (14), tissues of boas (Boa constrictor) and
a water python (Liasis mackloti) (15), and various vertebrate and
invertebrate transcriptomes (16). The snake- and duck-associated
sequences, although highly distinct from HDV, show predicted
similarity in secondary structure to the HDV ribozyme element.
Amino acid motifs known to have functional importance for HDV
replication occur in both sequences. However, the sequences de-
scribed by Chang et al. (16) lack the two ribozyme structural ele-
ments and some of the functional motifs, as well as experimental
proof of the viral replication mechanism. Also, the natural history of
disease, if transmissible, is not known for these putative viruses.
Here we describe a unique mammalian deltavirus from the
neotropical rodent species Proechimys semispinosus, tentatively
named rodent deltavirus (RDeV). We initially discovered the
viral RNA following undirected next-generation sequencing of
blood samples. Our study of 763 animals provides epidemio-
logical and virological evidence for a transmissible and prevalent
infection with a delta-like agent in a specific host. Surprisingly,
and in striking contrast to human HDV, we neither find a liver-
specific tropism of RDeV nor epidemiological or functional ev-
idence of coinfection with a hepadnavirus in the animals studied.
Results
In an ongoing study in the Panama Canal area, focused on the
effects of habitat disturbance on the infection rate with rodent
Hepacivirus (SI Appendix, Fig. S1) (17), we subjected blood samples
of 120 individuals of P. semispinosus to total RNA sequencing
(RNA-seq) using the Illumina MiSeq platform. High bit-score
matches to human HDV were obtained after comparing de novo
assembled sequences with a viral reference library (18). Based on
mapping against a reference alignment of all known HDV geno-
types, we compiled HDV-related sequences covering the whole
deltavirus genome from two individual animals. After aligning
these initial genome assemblies with HDV reference genotypes, we
designed an RT-PCR assay targeting a fragment in the coding
region of the rodent deltavirus antigen (RDeAg). The assay was
applied to pooled blood samples from 763 P. semispinosus indi-
viduals. Resolution of positive-testing pools resulted in 30 positive
individuals (overall detection rate 3.9%; 95% CI 2.6 to 5.3%). Only
adult animals were found positive. In addition to P. semispinosus,
we examined blood samples from individuals (n = 183) from 11
other rodent and marsupial species. No species other than P.
semispinosus yielded evidence of RDeV presence (SI Appendix,
Table S1).
Because HDV has a circular genome, we used primer pairs
whose 5′ ends are adjacent on reverse-complementary template
strands, with 3′ ends facing in opposite directions (Fig. 1B and SI
Appendix, Table S2). These primers can generate RT-PCR
amplicons covering the near-full deltavirus genome if the template
RNAmolecule is circular. This was successful in three samples with
high viral load (Fig. 1C). Genome circularity was further confirmed
by mapping RNA-seq reads from the respective samples to the
initial amplicon sequences, resulting in assemblies with protruding
ends that are identical, matching both ends of the amplicon, and
therefore derived from circular templates. Ten full circular RDeV
genomes and 10 partial genome assemblies were subsequently
obtained from the 30 initially RNA-positive samples by mapping
reads from individual RNA-seq datasets. PCR products for the
other 10 samples produced small fragments of less than 200 bases.
The nucleotide sequences of all 10 full genomes are 97.5 to 99.6%
identical. The sequences are available in GenBank under accession
numbers MK598003 to MK598012.
Major structural and functional HDV domains are present in
all recovered RDeV sequences (Fig. 1A and SI Appendix, Fig. S2
and Table S10), including a single open reading frame (ORF)
representing the delta antigen. A 19-amino acid tail that differ-
entiates the S-HDAg from the L-HDAg in human HDV is
present in RDeV, though with a different amino acid composi-
tion. This tail is the result of antigenomic editing at a site cor-
responding to the amber stop codon in the S-HDAg ORF of
human HDV (SI Appendix, Fig. S3). There is no experimental
evidence of RNA editing or large-antigen expression in RDeV,
as discussed below. In addition, the farnesylation motif CXXQ in
the HDV L-HDAg C terminus, required to acquire the HBV-
derived envelope (8), is absent in all P. semispinosus deltavirus
sequences.
Predicted secondary structures of genomic and antigenomic
ribozymes are highly similar between human and rodent delta-
virus (SI Appendix, Fig. S4). The ribozyme active site is identical
between rodent and human virus on both antigenomic and ge-
nomic strands. The nuclear export sequence motif and the nuclear
localization signal of S-HDAg are also present in the S-RDeAg.
Evidence for the existence and functionality of the nuclear local-
ization signal is provided by the occurrence of the small delta
antigen in the cell nuclei of HuH7 cells overexpressing S-RDeAg
(Fig. 2A).
Deltavirus Phylogeny. Nucleotide and amino acid sequences were
compared as summarized in SI Appendix, Fig. S2 and Table S3.
Phylogenies were calculated based on full-genome nucleotide
sequence alignments, as well as translated small delta antigen-
coding sequences. Both tree topologies are equivalent and the
distinction of RDeV from human HDV is clear (the full-genome
phylogeny is shown in Fig. 3). The nonhuman deltaviruses are
highly diverged and therefore chosen to root the phylogeny. The
snake deltavirus (SDeV) clusters with the rodent deltavirus, and
both form a highly diversified and well-supported sister group to
human HDV, with HDV genotype 3 being the most divergent
among HDV genotypes. All other nonhuman deltaviruses group
together consistently, although without significant bootstrap
support among subclades, owing to their high sequence diver-
gence. RDeV is most closely related to human HDV, as aver-
aged over all 1,000 bootstrap replicate trees (Fig. 3).
Organ Distribution of RDeV RNA and Protein Detection. To obtain
insight into the infection pattern caused by the rodent deltavirus,
we tested for viral RNA in organs of 18 animals that were found
dead during sampling (note that we followed a noninvasive
sampling approach and animals could not be purposefully eu-
thanized during our study). One of these animals tested RDeV
RNA-positive in all available organs (liver, kidney, lung, heart,
and small intestine), but its organ-specific RNA concentrations
did not suggest specific virus replication in the liver (SI Appendix,
Table S4). Also, a commercial HDV antigen enzyme-linked
immunosorbent assay that we found to cross-detect with RDeV
did not identify organ-specific protein expression in the liver,
lung, small intestine, heart, or kidney of this animal (SI Appendix,
Fig. S5A). To further understand potential virus excretion, fecal
samples from 822 individuals were tested by RT-PCR, 10 of
which were positive for RDeV RNA (the numbers of individuals
tested for each type of material are summarized in SI Appendix,
Table S5). This 1.2% detection rate was significantly lower than
that in blood samples (χ2 test, P < 10−4). The average virus
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concentration in fecal samples was 2.9 × 109 RNA copies per
gram, with a maximum concentration of 2.2 × 1010 copies per
gram. Average and maximum concentrations in blood were 1.8 ×
108 and 2.1 × 109 copies per milliliter.
RDeV Genome Replication. Rodent deltavirus genome replication
was confirmed by Northern blot analysis, as well as by clonal
expansion of RDeV-transfected cells. The full RDeV genome
was cloned as a tandem head-to-tail fusion dimeric construct in
genomic (minus-strand) orientation downstream of a cytomeg-
alovirus (CMV) promoter (see the construct map in SI Appendix,
Fig. S6) and transfected into HuH7 cells. Antigenomic RDeV
RNA as a marker of ongoing RDeV replication was detected in
transfected cells at all time points (Fig. 2F). The expression of
antigenomic RDeV RNA was accompanied by a robust synthesis
of genomic RDeV RNA (SI Appendix, Fig. S5D). Massive clonal
expansion of RDeV-transfected cells verifies the autonomous
replicating nature of RDeV, even exceeding HDV clonal expan-
sion as determined by immunofluorescence staining (Fig. 2G).
Deltavirus Antigens and Editing of the Amber Codon. One key fea-
ture of HDV is the expression of two viral proteins (S-HDAg and
L-HDAg) from a single ORF. A 19-amino acid carboxyl-terminal
extension differentiates the S-HDAg (195 codons) from the
L-HDAg (214 codons) in human HDV. This extension is the
result of antigenomic editing by cellular adenosine deaminase
acting on RNA 1 (ADAR1) at a site corresponding to the amber
stop codon in the S-HDAg ORF of the circular antigenomic
HDV RNA, edited from a UAG to a UIG codon. Following
HDV RNA replication, the UIG codon is converted into a
tryptophan codon (UGG) (SI Appendix, Fig. S3) during subse-
quent HDV messenger RNA (mRNA) synthesis, allowing ex-
pression of the L-HDAg (20). Interestingly, a 19-amino acid
carboxyl-terminal extension is present in RDeV, though differ-
ent in 15 of the 19 amino acids. To investigate potential RDeV
large antigen (L-RDeAg) expression, the full RDeV genome was
cloned as a tandem head-to-tail fusion construct in genomic
(minus-strand) orientation downstream of a CMV promoter (see
the construct map in SI Appendix, Fig. S6) and transfected into
HuH7 cells. As positive controls, S- or (hypothetical) L-RDeAg
was expressed under the control of a CMV promoter. Specific S-
or L-RDeAg expression was examined with antibodies from
rabbits immunized with synthetic peptides against S-RDeAg
(Fig. 2A) or the putative 19-amino acid extension of L-RDeAg
(Fig. 2B). The tandem genome construct expressed S-RDeAg
but not L-RDeAg (Fig. 2 A and B).
Corresponding results were obtained by Western blot analysis
of RDeV dimer transfection experiments using a broadly cross-
reactive human anti-HDV serum (Fig. 2 H, Upper). Evidence for
the absence of RNA editing on the RDeAg ORF was also
obtained from RNA-seq data. Mapping of reads from total RNA
blood and organ extracts of infected animals and from trans-
fected RDeV dimeric genome constructs in cell culture yielded
only unedited reads, whereas both edited and unedited reads
were detected for human HDV in a control experiment (SI Ap-
pendix, Fig. S3). In summary, there is no experimental evidence of
A
B C
Fig. 1. (A) Genome organization of human HDV, RDeV, SDeV, duck-associated DeV, newt DeV, toad DeV, fish DeV, and termite DeV. Delta antigen-coding
regions, functional and structural motifs, as well as post-translational modification sites. (B) Primer-binding positions for the circularization assays shown in
their locations on the RDeV genome. Primer names and sequences are listed in SI Appendix, Table S2. Blue, circularization assay 1 (CA1); red, circularization
assay 2 (CA2); green, circularization assay 3 (CA3). External primers are shown in dark color, and nested primers in light color. The S-RDeAg ORF is shown for
orientation. (C) Exemplary results from CA1 and CA3 obtained from total RNA blood extracts of three RDeV RNA-positive P. semispinosus. Fragment sizes are
1,608 bp for CA1 and 1,532 bp for CA3; label correspondence to RDeV GenBank accession numbers: 377, MK598006; 1481, MK598003; 976, MK598009.
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RNA editing on the RDeV antigen ORF or of large-antigen
expression during RDeV replication in vivo or in vitro.
Search for Signs of Hepadnaviral Coinfection. Because human HDV
transmission requires an envelope protein provided by an active
coinfection with HBV, we subjected all 763 P. semispinosus
blood samples to PCR screening for hepadnaviruses. The assay
was designed to detect all mammalian orthohepadnaviruses, in-
cluding those from rodents, bats, and primates (21). None of the
samples tested positive. Specific reanalysis of all available tran-
scriptome datasets from the present study did not yield any ev-
idence for orthohepadnaviral genomes in a basic local alignment
search tool (BLAST) analysis. All blood samples with sufficient
volume, whether RNA-positive or -negative for RDeV (n = 68),
were tested for antibodies against woodchuck HBV core antigen
(WHcAg). This antigen was chosen because the woodchuck is
most closely related to Proechimys among known HBV hosts. In
previous studies, we demonstrated that anti-HBc antibodies
broadly cross-react among HBVs from different hosts, even
across mammalian orders (21), so it is likely that WHcAg would
be bound by antibodies against a possible HBV in Proechimys.
However, no such antibodies were found in any of the tested
samples (Fig. 2D).
Investigation of Hepacivirus as Potential Cofactor. Experimental evi-
dence shows that apart from HBV, other viruses, including hep-
atitis C virus (genus Hepacivirus), can provide envelope proteins
for human HDV (22). As we previously detected a high preva-
lence of hepacivirus in the rodents studied (17), this possibility was
investigated. Overall, we found 4 out of 30 RDeV RNA-positive
rodents in which hepacivirus was not detected by the tests initially
applied (SI Appendix, Table S6). To exclude having missed hep-
acivirus detection, we applied RT-PCR assays specifically
designed for the E1, NS3, and NS5B genes of P. semispinosus
hepacivirus to those samples. All four animals were confirmed to
be hepacivirus RNA-negative by these assays as well as by RNA-
seq read mapping against P. semispinosus hepacivirus. Statistical
analysis of the degree of dependency between deltavirus and
hepacivirus infection in individuals was conducted, providing no
support for a dependency between the two infections (SI Appen-
dix, Table S6; χ2 test, P = 0.24). Also, analyses of sampling site-
specific deltavirus and hepacivirus detection rates (SI Appendix,
Table S7) did not reveal any correlation between deltavirus and
hepacivirus (Pearson’s correlation coefficient, ρ = 0.15), arguing
against a linear correlation. Logarithmic and linear regression fits
did not yield significant associations either, suggesting that the two
viruses follow different patterns of distribution. We conclude that
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Fig. 2. (A and B) Immunofluorescence staining of HuH7 cells transfected
with plasmids expressing S-RDeAg (A), a stop codon mutant expressing a
hypothetical L-RDeAg (B), as well as an intact dimer of the RDeV genome
(both panels). Cell nuclei were stained with DAPI; delta antigens were de-
tected with anti-HDAg immunoglobulin G (IgG) from an HDV/HBV-coin-
fected patient followed by an Alexa 568-labeled goat anti-human antibody
(red); S- or L-RDeAg was identified using S- or L-RDeAg–specific peptide
antisera from immunized rabbits, followed by an Alexa 488-labeled goat
anti-rabbit antibody (green). Channels are overlaid for both panels. (C) Im-
munofluorescence staining of L-RDeAg expression in Vero B4 cells with
HDAg-reactive human and P. semispinosus serum samples. Cell nuclei were
stained with DAPI (blue); FLAG-tagged L-RDeAg was detected using a mouse
anti-FLAG antibody followed by a goat anti-mouse Cy3-labeled antibody
(red); reactivity of human and P. semispinosus serum against L-RDeAg is vi-
sualized by an Alexa 488-labeled goat anti-human and goat anti-guinea pig
antibody, respectively (green). Nonreactive human and P. semispinosus se-
rum samples are shown for comparison. (D) Immunofluorescence staining of
HBcAg expression in HuH7 cells with anti-HBc–specific rabbit antiserum
(Upper) and P. semispinosus serum (Lower) samples. Cell nuclei are stained
with DAPI (blue); expression of HBcAg is visualized using a Cy2-labeled
secondary antibody (green). Channels are merged for both panels. (Scale
bars, 30 μm.) (E) Specific reactivity of P. semispinosus sera against S-RDeAg in
a Western blot. Total protein extracts from HuH7 cells overexpressing
S-RDeAg were separated by sodium dodecyl sulfate/polyacrylamide gel
electrophoresis and blotted. The membranes were incubated with five P.
semispinosus serum samples (IDs shown in figure) followed by a goat anti-
guinea pig horseradish peroxidase (HRP) antibody. Anti-S-RDeAg–specific
peptide antiserum from an immunized rabbit was used as positive control,
with goat anti-rabbit HRP as secondary antibody. (F) Northern blot of anti-
genomic RDeV RNA from transfected HuH7 cells. The cells were transfected
with an expression plasmid containing an intact dimer of the RDeV genome.
Total RNA was isolated 4, 6, 8, and 10 d posttransfection (dpt) and subjected
to a 1% denaturing formaldehyde agarose gel. After blotting, the RNA was
hybridized with a single-stranded oligonucleotide probe labeled with [γ-32P]
ATP and T4 polynucleotide kinase at the 5′ end. In vitro-transcribed antige-
nomic RDeV RNA was used as positive control. (G) Immunofluorescence
staining of HuH7 cells transfected with expression plasmids containing an
intact dimer of the RDeV genome, a mutant dimer of the RDeV genome
with abrogated S-RDeAg expression, and a trimeric genome of human HDV
genotype 1 [pSVL(D3)]. Cells (Left) were fixed on day 4 posttransfection. A
1:64 dilution of the cells (Left) were subjected to clonal expansion and fixed
on day 10 posttransfection (Right). Cell nuclei were stained with DAPI (blue)
and delta antigens were detected with anti-HDV IgGs followed by an Alexa
568-labeled goat anti-human antibody (red). (Scale bars, 100 μm.) (H) Detec-
tion of deltavirus antigens from HDV- and RDeV-transfected HuH7 cells by
Western blot. HuH7 cells were transfected with a dimeric RDeV genome and
a trimeric genome of human HDV genotype 1 [pSVL(D3)], and total protein
was isolated on 4, 6, 8, and 10 d posttransfection. S-RDeAg (Upper) and S-
and L-HDAg (Lower) were detected using cross-reactive human anti-HDV
serum; beta-actin was detected by an anti-beta-actin antibody.
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RDeV infection in P. semispinosus does not depend on active
hepacivirus infection.
Immune Reaction in RDeV-Infected Animals. To determine whether
RDeV causes an immune reaction in P. semispinosus, serum
samples were subjected to an indirect immunofluorescence assay.
L-RDeAg was cloned and transiently expressed in Vero B4 cells,
as described (23). Fig. 2C shows the reactivity of antibodies from
human sera against L-RDeAg, along with examples of reactive
and nonreactive P. semispinosus sera. At a dilution of 1:100, 17 of
30 RDeV RNA-positive and 3 of 115 RDeV RNA-negative ani-
mals tested positive for anti-RDeAg antibodies (P < 10−6, χ2 test).
To exclude RNA degradation in the case of antibody-positive
samples for which RDeV RNA was not detected, we applied a
real-time RT-PCR assay to detect RNA transcripts of a host
housekeeping gene (TATA-binding protein) (SI Appendix, Table
S8). The 20 positive sera were additionally tested at 1:1,000 di-
lution, testing positive in 5 cases. Western blots of these sera
against expressed S-RDeAg confirmed the specificity of serum
antibodies (Fig. 2E). The average RDeV RNA concentration in
all anti-RDeAg-positive sera was 262,400 RNA copies per mi-
croliter of blood. The average RDeV RNA concentration in only
those samples that tested antibody-positive up to a dilution of
1:1,000 was 8,500 RNA copies per microliter of blood (SI Ap-
pendix, Fig. S5C). These concentrations were significantly differ-
ent (P < 0.05, Mann–Whitney U test), which suggests that an
adaptive immune response can potentially limit or eliminate viral
replication. Elimination is also suggested by the occurrence of
three anti-RDeAg antibody-positive but RDeV RNA-negative
animals.
Ecological Factors That Influence Rodent Deltavirus Infection. The
study area in the Barro Colorado Nature Monument consists of is-
lands and peninsulas with different densities of populations of P.
semispinosus, a generalist species that can adapt to environmental
changes (24) and thus (relatively) competitively benefit from an-
thropogenic habitat disturbance. We have previously noted a positive
correlation between site-specific P. semispinosus population density
and the detection rate of hepacivirus infection (SI Appendix, Table
S7) (17). For rodent deltavirus, a different site-specific distribution
was observed (SI Appendix, Table S7). Highest detection rates were
identified in continuous forest sites that have largely preserved the
primordial habitat composition that existed before the flooding of
the Gatún Lake area during the construction of the Panama Canal.
Lower detection rates were found on forested islands, and minimal
rates in forest fragments surrounded by agriculture. To identify en-
vironmental factors that might correlate with rodent deltavirus
transmission, host- and habitat-specific properties were examined
under two different logistic regression models (SI Appendix, Table
S9). RDeV infection was found to be positively correlated with male
sex and reproductive activity, as well as with inhabiting continuous
forest sites with undisturbed habitat. In addition to the variables
shown in SI Appendix, Table S9, other habitat-specific factors such as
population density, canopy height and coverage, and understory
density did not add explanatory power to the analysis. The inclusion
of site-specific data on mosquito diversity narrowed the sample size
to n = 686 individuals for sampling sites where these data were
available. There was no detectable correlation between mosquito
diversity and RDeV detection rate.
Discussion
The present results enhance our understanding of the evolution
of hepatitis delta virus, a satellite virus to HBV and until recently
the only human RNA virus with no known counterpart in other
animals. The first question that must follow the discovery of
novel deltavirus-like sequences in rodent, reptile (15), and pu-
tatively avian (14) and other vertebrate and invertebrate hosts
(16) is whether these represent transmissible viruses as opposed
to, for example, endogenous viral elements. Hetzel et al. (15)
demonstrated protein expression in organs of those snakes in
which viral sequences were detected, and Szirovicza et al. (25)
showed that snake deltavirus can replicate in several cell lines.
Our reverse genetic and clonal expansion experiments now prove
the existence of mammalian nonhuman deltavirus genomes as
self-replicating viral entities, in which genomic replication in-
volves an internal initiation of replication. Moreover, correla-
tions of serology and virus detection in a natural animal
population of considerable size demonstrate that rodent delta-
virus infection is acquired during the course of life and is likely to
be cleared by an active immune response. Previous observations
on the snake deltavirus corroborate this infection pattern,
showing that although snake deltavirus infection was found in
both maternal and offspring boas (15), not all offspring were
infected, and snakes with no kinship to the mating pairs exhibited
both the presence and absence of the virus. Horizontal trans-
mission seems likely in both rodent and reptile deltaviruses. The
significantly lower detection rate of viral RNA in stool samples
compared with blood suggest blood-borne rather than fecal-oral
transmission. The observed predominant infection of adult males
is compatible with transmission through competitive behavior.
The novel deltaviruses associated with diverse hosts warrant
considerations regarding evolutionary origins. Phylogeny suggests
that fish- and amphibian-associated viruses are most distant from
other known deltaviruses, while snake and rodent viruses are
significantly closer to the HDV common ancestor. Considering the
relationship of these hosts, the tree topology seems to disfavor
Fig. 3. Maximum-likelihood phylogeny based on a full-genome alignment
of HDV representatives from the eight different genotype groups and RDeV,
SDeV, duck-associated DeV, newt DeV, toad DeV, fish DeV, and termite DeV.
The phylogenetic inference was done using RAxML-NG version 0.7.0 BETA
(19). Asterisks indicate bootstrap support >80 and tree tips show GenBank
accession numbers. The tree is rooted to the branch leading to the nonhu-
man DeVs. Distribution of evolutionary distances (branch lengths, extracted
from 1,000 bootstraps) for all nonhuman DeVs relative to the common an-
cestor of HDV (arrow on tree) is shown in the boxplots. The boxplots show
median, interquartile range, Tukey’s minimum and maximum (whiskers),
and extreme outlier values (dotted).
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virus-host codivergence. Besides, the duck-associated virus was not
detected in an internal organ but in cloacal and oropharyngeal
swabs, leaving open the possibility of contamination from ali-
mentary sources (14). The phylogenetic branch pattern supports
previous work on human HDV phylogeny, suggesting that HDV
genotype 3 stems from the oldest common ancestor of human
HDV genotypes (26). As this ancestor is more closely related to
the rodent virus than to any of the nonmammalian deltaviruses,
this would be compatible with the hypothesis that human and
rodent deltaviruses have codiverged with mammalian lineages.
Deltaviruses in other mammals may remain to be discovered, but
equally may now be extinct. A hypothesis of codivergence would
be corroborated by the discovery of at least one more mammalian
virus whose phylogenetic position reflects that of its host in rela-
tion to humans and rodents. The clustering of rodent and snake
viruses might then be interpreted as a sign of cross-species ac-
quisition from mammals. It is noteworthy that the parental boas
carrying the snake deltavirus stemmed from Panama, like the
rodents studied here (15). Human HDV genotype 3 is also found
in South and Middle America, but this alone should not be taken
as support to claim cross-host transmission.
The dependence of HDV on HBV coinfection for transmission
may have evolved only in a mammalian viral lineage leading to
human HDV, given that hepadnaviruses occur in diverse mam-
malian species including rodents, bats, and particularly New
World primates (21, 27, 28). Based on the lack of large-antigen
expression and a farnesylation motif, both necessary for interac-
tion with hepadnaviral envelope proteins, as well as on evidence
from epidemiological and serological data, we can exclude the
presence of HBV coinfection in deltavirus-infected P. semi-
spinosus. Neither HBV DNA nor anti-HBc antibodies were de-
tected in any animals infected with the deltavirus. In all other
deltavirus studies, no sequences of coinfecting hepadnaviruses
were found in transcriptome data. Other coinfecting viruses were
identified in each of these studies, designating their envelope
proteins as a potential source for an RDeV envelope (14–16). As
very recently shown by Szirovicza et al. (25), snake deltavirus can
produce infectious viral particles in vitro by utilization of envelope
proteins from arenaviruses and orthohantaviruses.
In the present study, we investigated the potential influence of
hepacivirus infection. Despite a high hepacivirus prevalence in the
studied rodents [ca. 80% (17)], we found four deltavirus RNA-
positive individuals lacking a hepacivirus coinfection. Human
HDV has been found to produce infectious particles in vitro with
the help of an envelope protein from hepatitis C virus, with the
required presence of an L-HDAg farnesylation motif (22). Given
the absence of this motif in the rodent delta antigen and the lack
of a hepacivirus coinfection in some individuals carrying deltavirus
RNA, we do not consider deltavirus infection to depend on hep-
acivirus infection in these rodents. In addition, we screened indi-
vidual RNA-seq datasets from 120 animals and did not identify
any other infectious viral agent in any deltavirus RNA-positive P.
semispinosus. There are multiple alternatives that may have
resulted in rodent deltavirus transmission. One possibility is the
presence of a currently unknown virus, bacterium, or integrated
sequence that provides an envelope protein to rodent deltavirus.
Furthermore, recent advances in cellular cross-communication
have revealed the exchange of extracellular vesicles containing
mRNA, circRNA, and other noncoding RNA molecules (29). It
should be investigated whether rodent deltavirus might employ
such pathways for transmission.
In their study of snake organ samples, Hetzel et al. (15) found
two bands of ca. 20 and 27 kDa in Western blots using an
anti-S-SDeAg serum. While the larger band might correspond to
a larger protein variant, expression of an actual L-SDeAg was
not confirmed by specific anti-L-SDeAg immunoblots, analyses
of RNA editing, or experimental studies of gene expression. The
present data, based on all these approaches, show that the
related rodent virus does not express a large delta antigen,
suggesting that the use of L-HDAg may have evolved only in
connection with the utilization of the HBV envelope. In this
scenario, the encounter with hepadnaviruses may have selected
for viral variants with a farnesylation signal in an L-HDAg tail
that is expressed by an initially low-level editing activity or stop
codon readthrough, allowing these viruses to exploit a novel
transmission opportunity by acquisition of an HBV envelope.
The sequence information from the present study can now be
used in directed searches for deltaviruses in other mammalian
species, even in the absence of HBV infection.
Alternative hypotheses of HDV origin have suggested either a
viroid origin (perhaps via an insect vector) or derivation from a
host DIPA gene (reviewed in ref. 11). A viroid origin is supported
by the structural similarity of the HDV ribozyme to plant viroid
ribozymes, the genome circularity of both HDV and viroids, and
the interaction with common cellular proteins (30). Derivation
from the human genome has been suggested based on the in-
complete set of genes essential for replication, the occurrence of
HDV-like ribozyme elements in the human genome (31), and the
interaction of HDV with a human-derived protein (DIPA) (32).
The deltavirus findings do not increase or decrease support for the
viroid origin hypothesis but force us to consider the DIPA hy-
pothesis from a wider perspective. The rodent deltavirus ORF
shows 30% nucleotide and 22% amino acid identity when com-
pared with the DIPA ORF in mice and rats, at which levels sim-
ilarity due to chance must be considered as a likely explanation
(33). In addition to these caveats, the present results suggest that
other mammalian deltaviruses existed before the origin of human
HDV, and that precursors to these mammalian viruses existed in
other vertebrates (14–16). Alternate scenarios, specifically the
derivation of nonhuman deltaviruses from human HDV precur-
sors, seem unlikely, considering the genetic distances between
these viruses, the relatively short time span available for the
evolution of such diversity in the case of a human origin, and the
requirement that the human virus infect several nonhuman hosts.
It appears instead that deltavirus originated as an exogenous in-
fectious agent that established acute infection in mammals. The
present study provides a basis for the evolution of HDV, con-
firming the general understanding that RNA virus diversity
evolved along the major evolutionary lineages of their hosts (34).
Methods
Animals were captured using Sherman traps in the Barro Colorado Nature
Monument, Panama (17). RNA-seq experiments were done on an Illumina
MiSeq instrument. RT-PCR followed standard protocols, including for circular
genome amplification. Immunofluorescence assay (IFA) serology was based
on cells overexpressing the L-RDeAg or woodchuck WHc antigen under the
control of a CMV promoter. Viral full RDeV genome complementary DNA
was cloned as a monomer or head-to-tail dimer under the control of a CMV
promoter. A full description of methods is provided in SI Appendix,Materials
and Methods.
All fieldwork was carried out with full ethical approval (Smithsonian In-
stitutional Animal Care and Use Committee protocols 2013-0401-2016-A1-A7
and 2016-0627-2019-A2) and samples were exported to Germany with per-
mission from the Panamanian government (SEX/A-21-14, SE/A-69-14, SEX/A-
22-15, SEX/A-24-17, SEX/A-120-16, and SEX/A-52-17).
Data Availability. The rodent deltavirus complete genome sequences described
here are available inGenBank under accession numbersMK598003 toMK598012.
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